Due to the pleiotropic action of ET-1 signaling in several tumor settings, we asked if ET-1 may be involved in aberrant functions leading to CLL progression and relapse, i.e. prolonged survival, proliferation, microenvironmental support and chemoprotection. This evidence concerns the gene EDN1 and B-cell chronic lymphocytic leukemia.